ArticleTargeted oncology2026

Subcutaneous Amivantamab and Lazertinib in PALOMA-3: Efficacy, Safety, and Administration: A Vodcast.

Danny NguyenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.